With more competition in the vaccine race, INO stock lost much of its sheen. But don’t rule out Inovio Pharmaceuticals because it has critical advantages that others lack.
This stock has skyrocketed this year as part of the COVID-19 vaccine development race, but will the momentum continue?
Inovio Pharmaceuticals (NASDAQ: INO) has enjoyed a remarkable year so far by any standard. Inovio's shares have skyrocketed close to 350%. A lot could happen to derail the company's fast track to su
This stock has skyrocketed this year as part of the COVID-19 vaccine development race, but will the momentum continue?
The small biotech has some big hurdles to jump over the next few months.
Buying shares in this small-cap biotech hasn't made long-term investors rich -- at least, not yet.
Buy shares of a company that isn't profitable yet and doesn't even have consistent revenue. Inovio Pharmaceuticals (NASDAQ: INO) definitely fits the bill of a company that isn't generating a profit r
On Friday, shares of Inovio Pharmaceuticals (NASDAQ: INO) saw unusual options activity. After the option alert, the stock price moved up to $15.5. * Sentiment: BEARISH * Option Type: SWEEP * Trade
2020 is turning out to be a tale of two halves for Inovio Pharmaceuticals (INO).The vaccine maker's valuation increased 10-fold between January and early July, backed by vigorous coronavirus tailwinds

Why Inovio Pharmaceuticals Stock Is Up Today

04:42pm, Thursday, 13'th Aug 2020
After a rough week on the stock market for the biotech company, investors finally think the price is right.
Inovio’s Q2 earnings and lingering questions about its INO-4800 vaccine are combining for a big drop for INOP stock. The post Inovio Pharmaceuticals Shares Drop, Get a Downgrade appeared first on In

Why Inovio Pharmaceuticals Stock Is Up Today

12:42pm, Thursday, 13'th Aug 2020
After a rough week on the stock market for the biotech company, investors finally think the price is right.

Is Inovio Pharmaceuticals Stock a Buy?

12:33pm, Thursday, 13'th Aug 2020
Negative results from clinical trials or regulatory roadblocks can send shares of these companies plunging. On the other hand, investing in the right clinical-stage biotech stock can reap life-changi
I demonstrate why Pfizer is the best choice for dividend investors playing the Covid-19 vaccine theme.
Its experimental coronavirus vaccine has some of the best clinical data among the 167 candidates in development.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE